ClinicalTrials.gov
ClinicalTrials.gov Menu

Tumor Infiltrating Lymphocytes Adjuvant Therapy of Melanoma (TIL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00200577
Recruitment Status : Completed
First Posted : September 20, 2005
Last Update Posted : June 1, 2017
Sponsor:
Information provided by (Responsible Party):
Nantes University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2012
  Actual Study Completion Date : March 2012